These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
478 related items for PubMed ID: 15138592
1. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Wu XX, Ogawa O, Kakehi Y. Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592 [Abstract] [Full Text] [Related]
2. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin. Jin X, Wu XX, Abdel-Muneem Nouh MA, Kakehi Y. J Urol; 2007 May; 177(5):1894-9. PubMed ID: 17437844 [Abstract] [Full Text] [Related]
3. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y. Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444 [Abstract] [Full Text] [Related]
4. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine. Yang B, Keshelava N, Anderson CP, Reynolds CP. Cancer Res; 2003 Apr 01; 63(7):1520-6. PubMed ID: 12670899 [Abstract] [Full Text] [Related]
5. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin. Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O. Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437 [Abstract] [Full Text] [Related]
6. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B, Yang X, An L, Gao B, Liu X. Auris Nasus Larynx; 2010 Feb 01; 37(1):89-94. PubMed ID: 19574005 [Abstract] [Full Text] [Related]
7. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation. Ong PS, Chan SY, Ho PC. Int J Oncol; 2011 Jun 01; 38(6):1731-9. PubMed ID: 21455570 [Abstract] [Full Text] [Related]
8. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells. Duechler M, Stańczyk M, Czyz M, Stepnik M. Cancer Chemother Pharmacol; 2008 Apr 01; 61(5):727-37. PubMed ID: 17594095 [Abstract] [Full Text] [Related]
9. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM, Hirano T, Oka K. Cancer Chemother Pharmacol; 2003 Jul 01; 52(1):47-58. PubMed ID: 12750841 [Abstract] [Full Text] [Related]
10. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system. Lösler S, Schlief S, Kneifel C, Thiel E, Schrezenmeier H, Rojewski MT. Ann Hematol; 2009 Nov 01; 88(11):1047-58. PubMed ID: 19301004 [Abstract] [Full Text] [Related]
11. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells]. Gu S, Chen C, Jiang X, Zhang Z. Wei Sheng Yan Jiu; 2016 Jan 01; 45(1):87-92. PubMed ID: 26987203 [Abstract] [Full Text] [Related]
12. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro]. Wang T, Ma LM, Zhang HP, Wang HW, Yang LH, Qiao ZH. Zhonghua Zhong Liu Za Zhi; 2008 Mar 01; 30(3):188-91. PubMed ID: 18756933 [Abstract] [Full Text] [Related]
13. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells. Mizutani Y, Yoshida O, Miki T, Bonavida B. Clin Cancer Res; 1999 Sep 01; 5(9):2605-12. PubMed ID: 10499639 [Abstract] [Full Text] [Related]
14. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Ramos AM, Aller P. Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480 [Abstract] [Full Text] [Related]
15. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Jia P, Chen G, Huang X, Cai X, Yang J, Wang L, Zhou Y, Shen Y, Zhou L, Yu Y, Chen S, Zhang X, Wang Z. Chin Med J (Engl); 2001 Jan 15; 114(1):19-24. PubMed ID: 11779429 [Abstract] [Full Text] [Related]
16. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O. Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629 [Abstract] [Full Text] [Related]
17. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel. Shang D, Ito N, Kamoto T, Ogawa O. Urology; 2007 May 01; 69(5):1007-12. PubMed ID: 17482960 [Abstract] [Full Text] [Related]
18. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Vanhoefer U, Cao S, Minderman H, Toth K, Skenderis BS, Slovak ML, Rustum YM. Clin Cancer Res; 1996 Dec 01; 2(12):1961-8. PubMed ID: 9816155 [Abstract] [Full Text] [Related]
19. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine. Han YH, Kim SZ, Kim SH, Park WH. Int J Oncol; 2008 Jul 01; 33(1):205-13. PubMed ID: 18575767 [Abstract] [Full Text] [Related]
20. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH, Gupta V, Singh SV. Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448 [Abstract] [Full Text] [Related] Page: [Next] [New Search]